Clinical trials are studies that determine if a new treatment is safe and effective in people. More food allergy clinical trials are underway today than ever before. These studies are the key to preventing dangerous food allergy reactions and finding a cure.
Before a potential treatment can be tested in people, the U.S. Food and Drug Administration (FDA) reviews the results of many tests. The FDA also evaluates extensive data from clinical trials before allowing any drug or treatment to be marketed nationally.
Clinical trials are usually conducted at major medical centers. Funding for a study may come from a number of sources, including the federal government’s National Institutes of Health (NIH), nonprofit organizations such as FARE, and pharmaceutical or biotechnology companies.
Learn more about clinical trials and how you can make a difference in the search for new treatments and a cure.
What to Read Next
Patients and other key stakeholders partnering to develop a patient-centered food allergy research program informed by real-world experiences.
Through support for academic and industry research, FARE promotes the development of new therapies and offers hope for effective treatments.
FARE conceived and initiated this comprehensive 2016 report on food allergy in the U.S., which was released by the National Academies of Sciences, Engineering and Medicine to inform food allergy research and policy.